STAT+: FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus
Image Credit: STAT News

STAT+: FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus

Watchdoq November 14, 2024
For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz Pharmaceutical rival to Botox.

Read Full Article